FDA continues stretching its criminal enforcement capacity beyond US borders, moving into Southeast Asia, but the agency's Office of International Programs is shrinking its world footprint at the same time.
FDA Posts Investigator In Singapore, But Trims Foreign Office List
FDA's Office of International Programs consolidates its China offices to "strategically focus its resources." FDA shifts away from primarily a domestic focus to global as drug criminal organizations spread globally